A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with…

Overview of attention for article published in ESMO Open, March 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 51 Mendeley

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone… https://t.co/FpRwjVpkJz #prost…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.